Back
BrandywineGLOBAL-Dynamic US Large Cap Value ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
76
DVAL
BrandywineGLOBAL-Dynamic US Large Cap Value ETF
Last Price:
$14.44
Seasonality Move:
1.06%
Sell
44
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$112.11
Seasonality Move:
-13.08%
Buy
76
BrandywineGLOBAL-Dynamic US Large Cap Value ETF (DVAL)
is a Buy
Is BrandywineGLOBAL-Dynamic US Large Cap Value ETF a Buy, Sell or Hold?
-
The current BrandywineGLOBAL-Dynamic US Large Cap Value ETF [DVAL] share price is $14.41. The Score for DVAL is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
DVAL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.73. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DVAL Stock Price Chart
What is BrandywineGLOBAL-Dynamic US Large Cap Value ETF's stock price today?
-
The BrandywineGLOBAL-Dynamic US Large Cap Value ETF share price today is $14.41Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DVAL is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $111.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
DVAL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 45.3 | Sell |
| Chaikin Money Flow: | -3167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.8 | Buy |
| Relative Strength Index (14 RSI): | 56.8 | Buy |
| Chaikin Money Flow: | 32783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DVAL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.68 | Sell |
| 20-day SMA: | 14.54 | Sell |
| 50-day SMA: | 14.39 | Buy |
| 200-day SMA: | 14.01 | Buy |
| 8-day EMA: | 14.62 | Sell |
| 20-day EMA: | 14.55 | Sell |
| 50-day EMA: | 14.46 | Sell |
| 200-day EMA: | 14.17 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.65 | Buy |
| 20-day SMA: | 107.3 | Buy |
| 50-day SMA: | 106.17 | Buy |
| 200-day SMA: | 82.91 | Buy |
| 8-day EMA: | 44.16 | Buy |
| 20-day EMA: | 20.28 | Buy |
| 50-day EMA: | 8.6 | Buy |
| 200-day EMA: | 2.21 | Buy |
BrandywineGLOBAL-Dynamic US Large Cap Value ETF Earnings Growth & DVAL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.
BrandywineGLOBAL-Dynamic US Large Cap Value ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||